Dishman Carbogen Amcis share price
You have to be logged in to add this to Watchlist.- ₹225.65(-1.63%)March 21, 2025 15:29:00 PM IST
- NSE
- BSE
- Vol : 244.67K (NSE + BSE)Last 20 day avg : 344.72 K
Dishman Carbogen Amcis is trading -1.63% lower at Rs 225.65 as compared to its last closing price. Dishman Carbogen Amcis has been trading in the price range of 232.65 & 225.65. Dishman Carbogen Amcis has given -15.21% in this year & 11.16% in the last 5 days. The company posted a net profit of 4.63 Crores in its last quarter.Listed peers of Dishman Carbogen Amcis include Rpg Life Sciences (-0.01%), Sequent Scientific (0.66%), Dishman Carbogen Amcis (-1.63%).The Mutual Fund holding in Dishman Carbogen Amcis was at 1.22% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Dishman Carbogen Amcis was at 8.75% in 31 Dec 2024. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 21, 2025, 05:05 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.64The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility2.07Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.41The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 4.80% from Rs 682.34 crore to Rs 651.09 crore, year-on-year
- Company has registered a profit of 4.63 cr vs a loss of 59.63 cr in the same quarter last year.
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 228.22
- R2
- 257.13
- R3
- 278.02
- S1
- 178.42
- S2
- 157.53
- S3
- 128.62
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Rpg Life Sciences | Bullish | 2,315.95 | -0.01 | 3,803.40 | 42.95 | 10.04 | 0.70 | - |
| Sequent Scientific | Bearish | 144.15 | 0.66 | 3,608.10 | - | 5.49 | - | 26.17 |
| Dishman Carbogen Amcis | Neutral | 225.65 | -1.63 | 3,537.81 | - | 0.63 | - | 9.46 |
| Gufic Biosciences | Bearish | 341.75 | -0.91 | 3,426.99 | 38.30 | 6.43 | 0.03 | 31.08 |
| Aarti Drugs | Moderately Bearish | 357.75 | 2.85 | 3,265.18 | 19.11 | 2.56 | 0.28 | 21.56 |
- Promoter(s) holds a high stake in the company at 59.32%
- FIIs are invested in this company
- FIIs holding has increased by 0.57 percentage points from previous quarter
- Mutual Funds holding has increased by 0.19 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-03-12 | To consider Fund Raising |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-05-30 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE385W01011
- BSE Code540701
- NSE CodeDCAL
Dishman Carbogen Amcis is trading at 225.65 as on Fri Mar 21 2025 09:59:00. This is -1.63% lower as compared to its previous closing price of 229.40.
The market capitalization of Dishman Carbogen Amcis is 3537.81 Cr as on Fri Mar 21 2025 09:59:00.
The 52 wk high for Dishman Carbogen Amcis is 307.80 whereas the 52 wk low is 132.75
Dishman Carbogen Amcis can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 26.46
- Dividend Yield: 0.00%
- D/E ratio: -
Dishman Carbogen Amcis reported a net profit of -153.45 Cr in 2024.
The Mutual Fund Shareholding was 1.22% at the end of 31 Dec 2024.